Summary
This prediction ended on 05.05.23 with a price of €4.61. Massive losses of -77.51% were the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Altimmune | 3.614% | 3.614% | -19.148% | -12.631% |
| iShares Core DAX® | 3.901% | 2.667% | 5.690% | 53.464% |
| iShares Nasdaq 100 | -2.603% | -7.934% | 19.505% | 72.276% |
| iShares Nikkei 225® | -0.545% | -9.754% | 46.053% | 63.079% |
| iShares S&P 500 | -0.881% | -1.488% | 16.911% | 60.400% |
According to BiotechBee what are the pros and cons of Altimmune for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Altimmune diskutieren
Buy mit Kursziel 38,0